Literature DB >> 18300235

Immunochemical analysis of HPV L1 capsid protein and p16 protein in liquid-based cytology samples from uterine cervical lesions.

Tomomi Yoshida1, Takaaki Sano, Tatsuya Kanuma, Nobuo Owada, Shinji Sakurai, Toshio Fukuda, Takashi Nakajima.   

Abstract

BACKGROUND: HPV L1 capsid protein is expressed together with the production of infectious viral particles, but its expression and relation to p16 expression, which has been a surrogate marker for human papilloma virus (HPV) infection in cervix, are little studied in cytology samples. The authors aimed to elucidate the relation between L1 capsid protein and p16 protein expressions in liquid-based samples from uterine cervical lesions.
METHODS: Immunochemical analyses using antibodies against L1 capsid protein and p16 protein were carried out on cytological materials obtained from uterine cervical lesions of low-grade squamous intraepithelial lesions (LSILs), high-grade squamous intraepithelial lesions (HSILs), and squamous cell carcinomas (SCCs).
RESULTS: L1 capsid protein was positive in 30% of LSILs and 12% of HSILs, but in 0% of SCCs. In contrast, p16 protein was positive in 55% of LSILs, 100% of HSILs, and 100% of SCCs. L1-positive cells were only observed in the superficial layer, whereas p16-positive cells were seen throughout the full thickness of the epithelium. The relation between L1 capsid protein and p16 protein, p16(-)/L1(+) cases represented 44% of LSILs, but 0% of HSILs, and 0% of SCCs, whereas p16(+)/L1(-) cases represented 82% of LSILs, 88% of HSILs, and 100% of SCCs.
CONCLUSIONS: Expression of L1 capsid protein decreased with lesion progression from LSILs to HSILs and SCCs, whereas p16 protein was positive in all HSILs and SCCs. The correlation between L1 and p16 expressions suggests that L1(-)/p16(+) cases have the potential for progression, whereas L1(+)/p16(-) and L1(-)/p16(-) cases may be nonprogressive lesions or potentially in remission. Copyright (c) American Cancer Society.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18300235     DOI: 10.1002/cncr.23366

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  15 in total

1.  Tailored immunotherapy for HPV positive head and neck squamous cell cancer.

Authors:  Neil Gildener-Leapman; John Lee; Robert L Ferris
Journal:  Oral Oncol       Date:  2013-10-11       Impact factor: 5.337

Review 2.  Antigen retrieval immunohistochemistry: review and future prospects in research and diagnosis over two decades.

Authors:  Shan-Rong Shi; Yan Shi; Clive R Taylor
Journal:  J Histochem Cytochem       Date:  2011-01       Impact factor: 2.479

Review 3.  [Precancerous lesions of the cervix. Biomarkers in cytological diagnosis].

Authors:  D Schmidt
Journal:  Pathologe       Date:  2011-11       Impact factor: 1.011

4.  HPV L1 capsid protein detection and progression of anal squamous neoplasia.

Authors:  Jonathan Hernandez; Abul Elahi; Erin Siegel; Domenico Coppola; Bridgett Riggs; David Shibata
Journal:  Am J Clin Pathol       Date:  2011-03       Impact factor: 2.493

5.  [Human papillomaviruses in the pathogenesis of intraepithelial neoplasia (AIN) and carcinoma of the anus].

Authors:  M von Knebel Doeberitz; M Reuschenbach
Journal:  Hautarzt       Date:  2010-01       Impact factor: 0.751

6.  Association of antibody to E2 protein of human papillomavirus and p16INK4A with progression of HPV-infected cervical lesions.

Authors:  Jureeporn Chuerduangphui; Chamsai Pientong; Piyawut Swangphon; Sanguanchoke Luanratanakorn; Ussanee Sangkomkamhang; Thumwadee Tungsiriwattana; Pilaiwan Kleebkaow; Ati Burassakarn; Tipaya Ekalaksananan
Journal:  Med Oncol       Date:  2018-05-09       Impact factor: 3.064

7.  Immunohistochemical detection of human papillomavirus capsid proteins L1 and L2 in squamous intraepithelial lesions: potential utility in diagnosis and management.

Authors:  Anna Yemelyanova; Patti E Gravitt; Brigitte M Ronnett; Ann F Rositch; Aleksandra Ogurtsova; Jeffrey Seidman; Richard B S Roden
Journal:  Mod Pathol       Date:  2012-09-21       Impact factor: 7.842

8.  Differential methylation of the HPV 16 upstream regulatory region during epithelial differentiation and neoplastic transformation.

Authors:  Svetlana Vinokurova; Magnus von Knebel Doeberitz
Journal:  PLoS One       Date:  2011-09-07       Impact factor: 3.240

9.  Clinical utility of Liqui-PREP™ cytology system for primary cervical cancer screening in a large urban hospital setting in China.

Authors:  Hao Deshou; Wang Changhua; Li Qinyan; Liu Wei; Fu Wen
Journal:  J Cytol       Date:  2009-01       Impact factor: 1.000

10.  Observations on the expression of human papillomavirus major capsid protein in HeLa cells.

Authors:  Chang-Yi Xiao; Bing-Bing Fu; Zhi-Ying Li; Gohar Mushtaq; Mohammad Amjad Kamal; Jia-Hua Li; Gui-Cheng Tang; Shuo-Shuang Xiao
Journal:  Cancer Cell Int       Date:  2015-05-23       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.